• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of specific imuune regulatoly drugs by the cell surface molecules.

Research Project

Project/Area Number 10557049
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field 内科学一般
Research InstitutionThe University of Tokyo

Principal Investigator

MORIMOTO Chikao  Institute of Medical Science, The University of Tokyo, Professor, 医科学研究所, 教授 (30119028)

Co-Investigator(Kenkyū-buntansha) KAWASAKI Hiroshi  Institute of Medical Science, The University of Tokyo, Assistant Professor, 医科学研究所, 助手 (80280957)
HOSONO Osamu  Institute of Medical Science, The University of Tokyo, Assistant Professor, 医科学研究所, 助手 (50190210)
TANAKA Hirotoshi  Institute of Medical Science, The University of Tokyo, Associates Professor, 医科学研究所, 助教授 (00171794)
TANAKA Toshiaki  Toray Industries, Inc., Group Leader (researcher), 基礎研究所, 主任研究員
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥12,600,000 (Direct Cost: ¥12,600,000)
Fiscal Year 1999: ¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 1998: ¥9,200,000 (Direct Cost: ¥9,200,000)
KeywordsCD26 / dipeptidyl peptidase IV / adenosine deaminase / T cell costimulation / mannose 6-phosphate / insulin-like growth factor II receptor / インスリン成長因子II受容体 / RANTES / MIP-1β / SDF-1α / リンパ球遊走 / HIV感染
Research Abstract

CD26 is the T cell activation antigen and also known to bind the adenosine deaminase (ADA) and have a dipeptidyl peptidase IV (DPPIV) activity. Cross-linking of CD26 and CD3 with immobilized monoclonal antibodies can deliver a second costimulatory signal and contribute to T cell activation. Our earlier studies revealed that the cross-linking of CD26 induced internalization of the molecules, subsequent tyrosine phosphorylation of signaling molecules and resulted in an enhanced proliferating responses of T cells. Although these findings suggests the importance of internalization in the function of CD26. CD26 has only 6 amino acid residues in its cytoplasmic region with no known motif for endocytosis. In this study, we have identified the mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGFIIR) as the binding protein for CD26, and the mannose 6-phosphate (M6P) residues in carbohydrate moiety of CD26 is critical for the binding between CD26 and M6P/IGFIIR. In human peripheral blood lymphocytes, T cell activation resulted in the mannose 6-phosphorylation of CD26. In addition, the cross-linking of CD26 with an anti-CD26 antibody induced not only capping and internalization of CD26 but also colocalization of CD26 with M6P/IGFIIR. Finally, internalization of CD26 by cross-linking and T cell proliferation induced by CD26 mediated T cell costimulation were inhibited by the addition of M6P, but not by the glucose 6-phosophate or mannose 1-phosphate. These results indicate that the interaction between mannose 6-phosphorylated CD26 and M6P/IGFIIR may play an important role in CD26-mediated T cell constimulatory signaling.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] Iwata S, Yamaguchi N, Munakata Y, Ikushima H, Lee JF, Hosono O, Schlossman SF, and Morimoto C.: "CD26/DPPIV differentially regulates the chemotaxis of T cells and monocytes toward RANTES"Int. Immunol. 11. 417-426 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Munakata Y, Umezawa Y, Iwata S, Dong R-P, Yoshida S, Ishii T and Morimoto C.: "Specific inhibition of Th2 type cytokine production from human peripheral T cells by terfenadine in vitro"Clin. Exp. Allergy. 29. 1281-1286 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hosono O, Homma T, Kobayashi H, Munakata Y, Nojima Y, Iwamoto A, and Morimoto C.: "Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals"Clin. Immunol.. 91. 295 (283)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kamiguchi K, Tachibana K, Ohashi Y, Fujita H, Iwata S, and Morimoto C.: "Cas-L is required for β1 integrin-mediated costimulation in T cells"J. Immunol.. 163. 563-568 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ohashi Y, Iwata S, Kamiguchi K, Morimoto C.: "Tyrosine Phosphorylation of Cas-L is a Critical Element for T Cell Receptor- and β1 Integrin-induced T Lymphocyte Migration"J. Immunol.. 163. 3727-3734 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Iwata S, and Morimoto C.: "CD26/Dipeptidyl peptidase IV in context: The different roles of a multifunctional ectoenzyme in malignant transformation"J. Exp. Med.. 190. 301-305 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Iwata S, Yamaguchi N, Munakata Y, Ikushima H, Lee JF, Hosono O, Schlossman SF, and Morimoto C.: "CD26/DPPIV differentially regulates the chemotaxis of T cells and monocytes toward RANTES."Int. Immunol.. 11. 417-426 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Munakata Y, Umezawa Y, Iwata S, Dong R-P, Yoshida S, Ishii T and Morimoto C.: "Specific inhibition of Th2 type cytokine production from human peripheral T cells by terfenadine in vitro."Clin. Exp. Allergy. 29. 1281-1286 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hosono O, Homma T, Kobayashi H, Munakata Y, Nojima Y, Iwamoto A, and Morimoto C.: "Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals."Clin. Immunol.. 91. 283-295 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kamiguchi K, Tachibana K, Ohashi Y, Fujita H, Iwata S, and Morimoto C.: "Cas-L is required for β1 integrin-mediated costimulation in T cells."J. Immunol.. 163. 563-568 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ohashi Y, Iwata S, Kamiguchi K, Morimoto C: "Tyrosine phosphorylation of Cas-L is a Critical Element for T Cell Receptor- and β1 Integrin-induced T Lymphocyte Migration."J. Immunol.. 163. 3727-3734 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Iwata S, and Morimoto C: "CD26/Dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation."J. Exp. Med.. 190. 301-305 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Iwata S,Yamaguchi N,Munakata Y,Ikushima H,Lee JF,Hosono O,Schlossman SF, and Morimoto C: "CD26/DPPIV differentially regulates the chemotaxis of T cells and monocytes toward RANTES"Int.Immunol.. 11. 417-426 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Munakata Y,Umezawa Y,Iwata S,Dong R-P,Yoshida S,Ishii T and Morimoto C.: "Specific Inhibition of Th2 type Cytokine production from human peripheral T cells by terfenadine in vitro"Clin.Exp.Allergy. 29. 1281-1286 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Hosono O,Homma T,Kobayashi H,Munakata Y,Nojima Y,Iwamoto A,and Morimoto C.: "Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals"Clin.Immunol.. 91. 283-295 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kamiguchi K,Tachibana K,Ohashi Y,Fujita H,Iwata S, and Morimoto C.: "Cas-L is required for β1 Integrin-mediated costimulation in T cells"J.Immunol.. 163. 563-568 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ohashi Y.Iwata S,Kamiguchi k,Morimoto C.: "Tyrosine Phosphorylation of Cas-L is a Critical Element for T Cell Receptor-and β1 Integrin-induced T Lymphocyte Migration"J.Immunol.. 163. 3727-3734 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Iwata S, and Morimoto C.: "CD26/Dipeptidyl peptidase IV in context:The Different roles of a multifunctional ectoenzyme in malignant transformation"J.Exp.Med.. 190. 301-305 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Hegen M: "Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase." Immunol.90. 257-264 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Dong R-P: "Different regulatory effects of pentoxifylline on human T cell activation pathways." J.Clin.Immunol.17. 247-252 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Dong RP: "Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation." J.Immunol.159. 6070-6076 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Shioda T: "Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α(SDF-1α) and SDF-1β are abolished by CD26/DPPIV-1 mediated cleavage." Proc.Natl.Acad.Sci.USA.95. 6331-6336 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Dong R-P: "Correlation of the epitope defined by anti-CD26 mAbs and CD26 function." Mol.Immunol.35. 13-21 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ohtsuki T: "Negative regulation of the anti-HIV and chemotactic activity of human stromal cell-derived factor 1α by CD26/DPPIV." FEBS Letter. 431. 236-240 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Morimoto C: "The structure and function of CD26 in the T-cell immune response." Immunol.Review.161. 55-70 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Iwata S: "CD26/DPPIV differentially regulates the chemotaxis of T cells and monocytes toward RANTES." Int.Immunol. (in press).

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi